Investments in Medical “Science Fiction”
Cancer: A Need Creating Novel Treatment Platforms
Stem Cell Sector Validating Itself With Exciting First Half 2012
Recent NewsChemistFrog Feeds from the Pond
These feeds are the daily and latest news from Yahoo Financials. Here from the Chemistfrog.com Pond we want to provide you with the necessary tools for your investment endeavors!
- Santarus and Pharming announce FDA acceptance for review of RUCONEST (recombinant human C1 esterase inhibitor) Biologics License Application
- Santarus and Pharming Announce FDA Acceptance for Review of RUCONEST (Recombinant Human C1 Esterase Inhibitor) Biologics License Application
- Vanda says Phase III study data shows cortisol rhythm restoration